drugset / Trial / NCT00361595
Intervenous (IV) Zoledronic Acid After Forteo in Postmenopausal Women
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the adequacy of zoledronic acid in maintaining bone mass after two years of treatment with Forteo, in postmenopausal women.
Timeline
- Start
- 2006-08
- Primary completion
- 2008-04
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zoledronic acid | Other / unclassified | 5 mg | Intravenous |